Senior Director, Global Patient Advocacy Lead

Location: United States - Boston preferred, or able to spend significant time in Boston; hybrid with regular domestic and international travel

Reporting to: Chief Operating Officer

About the role

Hemab is building preventative treatments for serious, underserved bleeding disorders. These are therapies designed to work with the body's own biology and stop bleeds before they start, instead of treating them after they happen. We're patient-first, science-led and clinical-stage - with a pipeline that takes different scientific approaches to different patient needs. We went public via our 2026 IPO, and we're scaling across two homes: Cambridge, MA, USA, and Copenhagen, Denmark.

Patients need a meaningful voice in how medicines are developed and how care changes around them. As Senior Director, Global Patient Advocacy Lead, you'll set Hemab's patient advocacy strategy, with a major near-term focus on building our presence, partnerships and understanding of patient communities in the US. Across Glanzmann Thrombasthenia, von Willebrand Disease and, increasingly, heavy menstrual bleeding, you'll build trusted partnerships where strong communities already exist and help create connections and infrastructure where they don't. Our work starts with patients who have spent too long reacting to bleeds rather than having the chance to prevent them. Patient advocacy at Hemab isn't separate from the science - it helps us understand what patients need and what meaningful progress looks like.

Hemab is still building a lot of its own structure. Systems here tend to get created as we need them, not handed down in advance. Whoever takes this role will likely build some of their own process instead of inheriting a finished one. We work across two hubs and multiple time zones - bridging that well takes real, deliberate effort. And because we're growing quickly, priorities can shift with less notice than they would at a larger, more established company. This is the actual shape of working somewhere at this stage: It's genuinely energising for the right person and genuinely frustrating for the wrong one. If you want a place where the operating manual is already written, this might not be it – but if you want to help write it, this might be exactly it.

At Hemab, your work ultimately connects back to something simple. People living with serious bleeding disorders get something they've never had before - the chance to prevent a bleed, instead of reacting to one after it happens. You'll be joining at a stage where individual decisions still carry real weight, and where your work can help turn promising science into a